19 Aug 08
BioCancell Announces Prof. Roger D. Kornberg Appointed to SAB
03 Aug 08
BioCancell Completes $3.65 Million Fundraising Round
24 Jul 08
BioCancell Appoints Prof. Alexander Levitzki to Board of Directors
17 Jul 08
BioCancell Requests Pancreatic Cancer Clinical Trial
22 Jun 08
BioCancell Therapeutics Approves $3.65 Million Investment
19 May 08
BioCancell & Pro-Pharmaceuticals Cancer Treatment Collaboration
15 May 08
BioCancell Completes Placement to Clal Biotechnology Industries
07 Apr 08
BioCancell Reveals Pancreatic Cancer Pre-Clinical Results
09 Mar 08
BioCancell Submits Pre-IND: Ovarian, Pancreatic & Liver Cancer
13 Jan 08
BioCancell Gets FDA Approval for Phase IIb Bladder Cancer Trial
19 Dec 07
BioCancell Announces Strategic Partnership & Clinical Trial Grant
13 Dec 07
BioCancell Submits IND for Phase IIb Bladder Cancer Clinical Trial
05 Dec 07
BioCancell Reports Successful Ovarian Cancer Treatment
23 Oct 07
BioCancell Announces Ovarian & Liver Pre-Clinical Effectiveness
24 Sep 07
BioCancell Announces Successful Results in Bladder Clinical Trial
08 Aug 07
BioCancell Reports Completion of First Part of Bladder Clinical Trial
